Company Filing History:
Years Active: 2010-2012
Title: Andrew Neil Bowler: Innovator in Pharmaceutical Compositions
Introduction
Andrew Neil Bowler is a notable inventor based in Gentofte, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of liquid, aqueous compositions containing Factor VII polypeptides. With a total of 3 patents to his name, Bowler's work is instrumental in advancing medical treatments.
Latest Patents
Bowler's latest patents focus on liquid, aqueous pharmaceutical compositions that are stabilized against chemical and physical degradation. These compositions contain Factor VII polypeptides and are designed for the treatment of Factor VII-responsive syndromes. The main embodiment of his invention includes a composition comprising at least 0.01 mg/mL of a Factor VII polypeptide, a buffering agent to maintain pH levels between 4.0 and 9.0, and a stabilizing agent featuring a specific motif, such as benzamidine and guanidine compounds like arginine.
Career Highlights
Andrew Neil Bowler is associated with Novo Nordisk Healthcare AG, a leading company in the pharmaceutical industry. His work at Novo Nordisk has allowed him to focus on innovative solutions that address critical health issues.
Collaborations
Bowler collaborates with esteemed colleagues, including Michael Bech Jensen and Anders Klarskov Petersen. Their combined expertise contributes to the advancement of pharmaceutical innovations.
Conclusion
Andrew Neil Bowler's contributions to pharmaceutical compositions highlight his role as a key innovator in the field. His patents and collaborations reflect a commitment to improving medical treatments and patient outcomes.